| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enliven Therapeutics, Inc. (ELVN) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. ELVN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 890.4K | $40.16M | - | |
| CEO | 875.0K | $39.46M | - | |
| Other | 740.2K | $33.38M | - | |
| 10% | 245.7K | $11.08M | -281,408 | |
| COO | 215.0K | $9.70M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2024 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 991 | $27.53 | $27,280.94 | -100% | +8.1% | -28.7% | |
| Jul 29, 2024 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 5,250 | $26.68 | $140,052.21 | -98.9% | +7.9% | -24.4% | |
| Jul 29, 2024 | Lyssikatos Joseph P50 | Chief Scientific Officer | Sell | 12,000 | $26.70 | $320,377.80 | -0.5% | +7.9% | -24.4% | |
| Jul 25, 2024 | Kintz Samuel51 | President And CEO | Sell | 12,000 | $24.92 | $299,072.62 | -0.4% | +15.8% | -15.3% | |
| Jul 16, 2024 | Patel Anish54 | Chief Operating Officer | Sell | 50,000 | $25.06 | $1,252,826.10 | -4.5% | +12.6% | -12.9% | |
| Jul 15, 2024 | Heyman Richard A.74 | Director | Sell | 1,270 | $24.80 | $31,496.76 | -0.9% | +10.6% | -13.7% | |
| Jul 12, 2024 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 3,000 | $25.07 | $75,195.00 | -100% | +9.0% | -9.3% | |
| Jul 1, 2024 | Lyssikatos Joseph P50 | Chief Scientific Officer | Sell | 12,000 | $22.89 | $274,736.40 | -1.1% | +12.5% | -13.4% | |
| Jun 27, 2024 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 4,250 | $22.57 | $95,921.55 | -50.8% | +3.3% | -11.8% | |
| Jun 25, 2024 | Kintz Samuel51 | President And CEO | Sell | 12,000 | $21.66 | $259,901.54 | -0.6% | +9.8% | +0.1% |